Matthews M - Search Results

1

Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse?

Schneider JP, Matthews M, Jamison RN. Schneider JP, et al. Among authors: matthews m. CNS Drugs. 2010 Oct;24(10):805-10. doi: 10.2165/11584260-000000000-00000. CNS Drugs. 2010. PMID: 20839893 Review.

2

Abuse-deterrent and tamper-resistant opioids: how valuable are novel formulations in thwarting non-medical use?

Lourenço LM, Matthews M, Jamison RN. Lourenço LM, et al. Among authors: matthews m. Expert Opin Drug Deliv. 2013 Feb;10(2):229-40. doi: 10.1517/17425247.2013.751095. Epub 2012 Dec 20. Expert Opin Drug Deliv. 2013. PMID: 23252692 Review.

3

Attitudes of Primary Care Practitioners in Managing Chronic Pain Patients Prescribed Opioids for Pain: A Prospective Longitudinal Controlled Trial.

Jamison RN, Scanlan E, Matthews ML, Jurcik DC, Ross EL. Jamison RN, et al. Pain Med. 2016 Jan;17(1):99-113. doi: 10.1111/pme.12871. Pain Med. 2016. PMID: 26304697 Clinical Trial.

4

Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers.

Jamison RN, Sheehan KA, Scanlan E, Matthews M, Ross EL. Jamison RN, et al. Among authors: matthews m. J Opioid Manag. 2014 Nov-Dec;10(6):375-82. doi: 10.5055/jom.2014.0234. J Opioid Manag. 2014. PMID: 25531955

5

Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically.

Suzuki J, Matthews ML, Brick D, Nguyen MT, Wasan AD, Jamison RN, Ellner AL, Tishler LW, Weiss RD. Suzuki J, et al. J Opioid Manag. 2014 May-Jun;10(3):159-68. doi: 10.5055/jom.2014.0204. J Opioid Manag. 2014. PMID: 24944066 Free PMC article.

6

Class-wide REMS for extended-release and long-acting opioids: potential impact on pharmacies.

Matthews ML. Matthews ML. J Am Pharm Assoc (2003). 2013 Jan-Feb;53(1):e1-7. doi: 10.1331/JAPhA.2013.12025. J Am Pharm Assoc (2003). 2013. PMID: 23636166 Review.

7

The role of dose reduction with NSAID use.

Matthews ML. Matthews ML. Am J Manag Care. 2013 Nov;19(14 Suppl):s273-7. Am J Manag Care. 2013. PMID: 24494606 Free article. Review.

8

A comparison of registered and published primary outcomes in clinical trials of opioid use disorder: ACTTION review and recommendations.

Kleykamp BA, Ferguson MC, McNicol E, Bixho I, Matthews M, Turk DC, Dworkin RH, Strain EC. Kleykamp BA, et al. Among authors: matthews m. Drug Alcohol Depend. 2022 Jul 1;236:109447. doi: 10.1016/j.drugalcdep.2022.109447. Epub 2022 Apr 7. Drug Alcohol Depend. 2022. PMID: 35580477 Review.

9

A combined recombinase polymerase amplification CRISPR/Cas12a assay for detection of Fusarium oxysporum f. sp. cubense tropical race 4.

Matthews MC, van der Linden J, Robène I, Rozsasi S, Coetzee B, Campa M, Burger J, Akwuruoha UN, Madufor NJ, Perold W, Opara UL, Viljoen A, Mostert D. Matthews MC, et al. Sci Rep. 2025 Jan 19;15(1):2436. doi: 10.1038/s41598-025-85633-8. Sci Rep. 2025. PMID: 39828694 Free PMC article.

10

Utilizing Simulated Telemedicine Encounters to Conduct Nationwide Studies of Physician Communication Practices.

Matthews MC, Patel MA, Rodenbach RA, Commers W, Campbell TC. Matthews MC, et al. J Palliat Med. 2025 Jan 17. doi: 10.1089/jpm.2024.0342. Online ahead of print. J Palliat Med. 2025. PMID: 39819041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,256 results

Search Page

Filters